Low-dose rapamycin and ovarian aging: first trial results show only small, untested differences

In a small randomized trial at Columbia University, 50 women aged 35 to 45 took a weekly low dose of rapamycin or a placebo for 12 weeks. A year later, a blood marker of the egg supply had fallen slightly less in the rapamycin group, but the posted results include no statistical test, and other measures did not line up. Registry results, not a peer-reviewed paper.

Randomized trial in people

In older Poles, slightly low hemoglobin was linked to higher death risk over ten years

In a nationwide Polish study of 3,806 people aged 65 and over, those whose blood hemoglobin was even a little below about 13.3 g/dL (women) or 13.9 g/dL (men) were more likely to die over the next ten years, even after other illnesses were taken into account. It is an observational study, and the cut-offs on their own predicted death only weakly.

Observational study in people

When several of the body's chemical systems drift off balance at once, risks seem to add up

In almost 10,000 Canadian adults, researchers measured how far each person's blood chemistry had drifted from that of healthy middle-aged people. The drift split into separate systems, and people who were far off in several systems at once had about three times the risk of dying during follow-up. It is an observational study and a preprint that has not yet been peer-reviewed.

Observational study in people

A tea compound was linked to slower aging in a US survey and helped worms live longer

In about 11,000 American adults, people whose diet included EGCG, a compound found mainly in tea, had blood tests that looked slightly younger and a lower risk of dying over eight years. In worms and mouse liver cells, EGCG worked through peroxisomes, small fat-burning compartments of the cell. The human part is observational, and the mechanism was shown only in worms and cells.

Animal and human data

Routine CT scans of 78,000 patients map how every vertebra and rib loses density with age

Using CT scans taken for other reasons in 78,620 patients at nine Japanese hospitals, researchers charted bone density at 25 vertebrae and 24 ribs from age 15 to 100. Density fell with age almost everywhere, and in women the fall was sharpest at about 52 years at every one of the 49 sites. The study is a snapshot of different people at different ages, not a follow-up of the same people, and it is a not yet peer-reviewed preprint.

Observational study in people

Adults who ate more protein per kilo of body weight looked biologically younger in a US survey

In 6,249 US adults, those who ate the most protein relative to their body weight were less likely to show signs of faster biological aging, measured with telomeres and three blood-and-body scores, and were less likely to die during follow-up. The data are a single snapshot of diet from two decades ago, so reverse causation cannot be ruled out, and the study is a not yet peer-reviewed preprint.

Observational study in people

Very low vitamin D was linked to more age-related disease in two huge health-record studies

In medical records of hundreds of thousands of adults in Israel and the US, people with severe vitamin D deficiency were more likely to die and to develop several age-related diseases over up to ten years. Pharmacy purchases of vitamin D were linked to lower death rates. The study is observational, so it cannot show that vitamin D itself made the difference, and randomized trials have given mixed results.

Observational study in people

Old mice made too much glucagon, the hormone that raises blood sugar

Diabetes research on aging has focused on insulin. A Spanish study finds that the pancreas cells making glucagon, insulin's opposite, also change in old mice, and that people with higher glucagon in a Spanish clinical trial were more likely to develop type 2 diabetes. The detailed work is in mice; the human part shows associations only.

Animal and human data